Neurocrine Biosciences (NBIX) - Market capitalization

Market cap: NZ$26.71 Billion

As of December 2025 Neurocrine Biosciences has a market cap of NZ$26.71 Billion. This makes Neurocrine Biosciences the world's 1372th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2025

End of year Market Cap

Year	Marketcap	Change
2025	NZ$26.71 B	6.74%
2024	NZ$25.03 B	22.29%
2023	NZ$20.47 B	13.19%
2022	NZ$18.08 B	52.89%
2021	NZ$11.82 B	-4.69%
2020	NZ$12.41 B	-15.72%
2019	NZ$14.72 B	52.36%
2018	NZ$9.66 B	-0.02%
2017	NZ$9.66 B	99.2%
2016	NZ$4.85 B	-31.93%
2015	NZ$7.12 B	227.03%
2014	NZ$2.18 B	184.81%
2013	NZ$0.76 B	26.7%
2012	NZ$0.60 B	0.4%
2011	NZ$0.60 B	10.73%
2010	NZ$0.54 B	229.9%
2009	NZ$0.16 B	-22.6%
2008	NZ$0.21 B	-6.18%
2007	NZ$0.22 B	-59.54%
2006	NZ$0.56 B	-83.55%
2005	NZ$3.40 B	35.02%
2004	NZ$2.52 B	-14.8%
2003	NZ$2.96 B	10.75%
2002	NZ$2.67 B	-28.66%
2001	NZ$3.74 B	98.17%
2000	NZ$1.89 B	84.91%
1999	NZ$1.02 B	314.37%
1998	NZ$0.24 B	2.89%
1997	NZ$0.24 B	-7.69%
1996	NZ$0.26 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Neurocrine Biosciences was reported to be:

NZ$26.71 Billion

by Nasdaq

NZ$26.71 Billion

by CompaniesMarketCap

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Repligen RGEN	NZ$15.63 B	-41.49%	🇺🇸 USA
Royalty Pharma RPRX	NZ$38.39 B	43.71%	🇬🇧 UK
Palatin Technologies PTN	NZ$80.94 M	-99.70%	🇺🇸 USA
Eli Lilly LLY	NZ$1.522 T	5,596.79%	🇺🇸 USA
AbbVie ABBV	NZ$681.29 B	2,449.82%	🇺🇸 USA
Pfizer PFE	NZ$248.96 B	831.78%	🇺🇸 USA
ANI Pharmaceuticals ANIP	NZ$3.17 B	-88.13%	🇺🇸 USA
Athersys ATHX	NZ$1.44 M	-99.99%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: NZ$26.71 Billion